Divine Healthcare Limited to Issue IPO, Appoints Muktinath Capital as Issue Manager
1st September 2026, Kathmandu
Divine Healthcare Limited has initiated the process to issue initial public offering (IPO) ordinary shares to the general public, appointing Muktinath Capital Limited as its issue and sales manager.
Divine Healthcare IPO Issue
IPO Issuance Agreement and Management Details
Agreement Signing: The issue management agreement was signed by Yubaraj Shrestha, Chairman of Divine Healthcare Limited, and Kabindra Bikram Dhoj Joshi, Chief Executive Officer of Muktinath Capital Limited, at the Muktinath Capital office.
Executive Attendance: The signing ceremony was attended by Divine Healthcare Managing Director Susanta Murarka along with Directors Manoj KC and Vinay Todi.
Share Allocation: The company plans to issue 20 percent of its total issued capital (comprising 2,070,000 ordinary share units) to the general public.
Company Infrastructure and Operations
Profile and Location: Established on Kartik 14, 2074 B.S. (2017), Divine Healthcare operates a pharmaceutical manufacturing facility spanning approximately one bigha in Vijay Nagar, Bharatpur Metropolitan City-16, Chitwan.
Regulatory Approvals: The company holds all mandatory manufacturing and marketing authorizations from the Department of Drug Administration and the Ministry of Health and Population.
Advertisement
Product Portfolio: Divine Healthcare currently manufactures and distributes 67 types of human medicines in the domestic market, including popular pharmaceutical product lines such as Acidex, Nexofast 5, and the Pregex Range.
Manufacturing Expansion: The company is preparing to start producing Dry Powder Inhaler (DPI) medications for Chronic Obstructive Pulmonary Disease (COPD) and kidney patients starting this coming Magh (January).
Financial Performance and Distribution Network
Financial Health: Divine Healthcare has reported consecutive profits for the last three fiscal years.
Financing Structure: Operations have been maintained primarily through internal equity capital without reliance on bank or financial institution loans.
Distribution Channel: The company distributes its pharmaceutical products nationwide through a network of over 125 distributors.
For More: Divine Healthcare IPO Issue
